Managed service contracts are seen as a valuable asset in the provision of modern pathology services. Now, Beckman Coulter is branding its next-generation offering as Three60,bringing with it a new level of support expertise.
Collaboration is now the new way of working in all industries and this is particularly important in the modern NHS. Healthcare professionals across all sectors are under pressure: they need to provide the best care in a reduced-cost environment.
In the modern laboratory, the managed service contract has become a valuable tool for improving efficiency and taking out non-value-added processes. It does this by offering a means of outsourcing some of the administrative burden of managing complex pathology services. Laboratory managers and hospital administrators are then able to devote more time to core laboratory requirements and value-added activities such as service development.
Furthermore, the complexity of the contracts is increasing, with multiple third-party suppliers being managed through the primary service provider who takes responsibility for their supply of goods and services to the hospital laboratory.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.